Building predictive computational models by harnessing the power of high performance computing and high-dimensional biosensor, biomarker and phenotypic data.
We are computational modelers, life science researchers, clinicians, and patient advocacy groups forging a unique cooperative alliance to transform our understanding of brain disorders and accelerate the discovery of new treatments and cures.
Our initial goal is to build the first robust computer simulation of multiple sclerosis to help predict the course of the disorder in individual patients and accelerate the discovery of new diagnostics, treatments and cures.
The former head of Johnson & Johnson's ($JNJ) initiative to develop stratified drugs for Alzheimer's disease is trying to crowdfund the development of computer simulations of brain disorders. Magali Haas is seeking $299,900 for the project, which builds on a multiple sclerosis prediction model created by her nonprofit, Orion...February 16, 2015
The 22nd International Molecular Medicine Tri-Conference is the industry’s Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology. Spanning six days this year, the Tri-Conference includes an expanded program that includes 6 symposia, over 20 short courses, and 17 conference programs.February 1, 2015
Webinar – February 26, 2015 – Mechanism-based CNS Disease Modeling: Applications in Neurology and Psychiatry Drug Research & Development
Mechanism-based CNS Disease Modeling: Applications in Neurology and Psychiatry Drug Research & Development
February 26, 2015 at 12pm ET
You are invited to attend the second installment of Orion Bionetworks’ webinar series held on February 26, 2015 at 12 noon ET. The webinar will feature Dr. Hugo Geerts, Chief Scientific Officer of In Silico Biosciences, who will discuss “Mechanism-based CNS Disease Modeling: Applications in Neurology and Psychiatry Drug Research & Development.”February 2, 2015